Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
newsdepo.com
Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets.Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets. Read more
